Physician

Sherryl Reed, M.D.

According to 2025 Medicare claims, Sherryl Reed, M.D. (NPI: 1578569984) practices internal medicine in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-1759. Reed is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 624 traditional Medicare patients, billed 41,938 HCPCS/CPT codes, and received $448,210 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 29,594 prescription claims across 980 beneficiaries totaling $3,244,655 in drug costs, led by Eliquis (Apixaban). DME data shows 468 claims. Open Payments data shows 150 records totaling $2,049. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,732,746 to $3,244,655. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $42,193 and ending at $60,343.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	955	22,977	$482,715
2016	1,062	23,733	$538,310
2017	1,058	24,219	$568,529
2018	1,061	24,105	$554,393
2019	1,017	27,005	$552,030
2020	902	28,445	$460,140
2021	933	24,180	$486,641
2022	670	19,895	$384,865
2023	565	32,334	$385,949
2024	624	41,938	$448,210

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	886	27,061	$1,732,746
2016	934	27,451	$1,810,055
2017	1,007	27,451	$1,926,263
2018	1,024	26,285	$2,045,248
2019	1,072	25,771	$2,131,186
2020	1,074	25,470	$2,328,706
2021	1,150	26,318	$2,545,311
2022	991	26,148	$2,576,864
2023	926	27,556	$2,874,238
2024	980	29,594	$3,244,655

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	309	1,110	$52,101
2016	279	1,120	$41,347
2017	211	754	$18,477
2018	173	980	$31,151
2019	207	972	$40,303
2020	181	812	$35,602
2021	116	688	$25,768
2022	85	590	$38,558
2023	67	496	$32,665
2024	83	468	$47,585

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	386	952	$76
80061	Blood test, lipids (cholesterol and triglycerides)	414	820	$13
83036	Hemoglobin a1c level	402	757	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	428	998	$8
80076	Liver function blood test panel	393	775	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	346	14,198	$273,773
Jardiance	Empagliflozin	229	9,180	$175,313
Ozempic	Semaglutide	155	5,308	$160,505
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	173	6,778	$140,268
Xarelto	Rivaroxaban	164	6,383	$115,939

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	17	78	$33,995
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	77	$5,463
E0784	External ambulatory infusion pump, insulin	Y	N/R	11	$3,617
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	30	92	$1,097
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	16	$652

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	150	$2,049	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sherryl Reed, M.D.?

Tedicare shows public-source Medicare data for Sherryl Reed, M.D. (NPI 1578569984), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sherryl Reed, M.D. have ACO affiliation data?

Sherryl Reed, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Sherryl Reed, M.D.?

Sherryl Reed, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Sherryl Reed, M.D. have Open Payments data?

Sherryl Reed, M.D. has 150 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.